+91 22 24172311
Sections
Search
Subscribe
Equity
Venture Capital
Private Equity
M&A

Mergers & Acquisitions | 17 January 2012

Dishman Pharma Acquires France Based - Creapharm Parenterals

by Irfan Khan
 
@irfan
Dishman Pharmaceuticals & Chemicals Ltd has acquired France based contract development firm - Creapharm Parenterals through it's wholly owned subsidiary - Carbogen Amcis AG.

As part of this acquisition, Creapharm Parenterals has changed its name to Carbogen Amcis SAS. Financial terms were not disclosed.

The acquisition will extend Carbogen Amcis’ range of development and manufacturing services by adding formulation, lyophilization services and sterile GMP capabilities for the development of drug products, including highly potent drugs, for preclinical studies and clinical trials.




Automatic Data Processing Acquires MaFoi Consulting From Ranstad

US based Automatic Data Processing has acquired Ma Foi Consulting Solutions Ltd from Randstad Holding Nv. for an undisclosed amount. As a part of this deal, ADP will take on a team of over 200 new associates.

Read More...

FreeCharge Secures Series B Funding

Freecharge, an online platform for recharge, utility payments, promotions and couponing, has raised $33 Mn (c.INR 2,000 Mn) from existing investor Sequoia Capital India along with new investors Belgium-based investment firm Sofina and Russian Internet and technology investor ru-Net. The Series B infusion will be taken to build up its transactional advertising offerings.

Read More...
CONTACT US
Info@DealCurry.com
+91 22 24172311
A 311, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.